Jupiter Life Line Hospitals · forward-looking guidance across the available source record.
Guidance tracker
While EBITDA margins will hold around current levels, the gap between EBITDA and PAT will widen through FY26 due to ~10 crore quarterly incremental depreciation and higher finance costs from last year's capex cycle.
Currently halfway through capex with ~200 crore already incurred; ~200 crore more to be spent. Hospital expected to achieve EBITDA break-even by Year 2 with ramp-up of 2-2.5 months to break-even as experienced in past greenfield projects.
Following the 15-25-60% thumb rule for project implementation over 3 years, Pune's next-phase spending will be approximately 15% of total project cost in FY27, with bulk of capex already behind.
Management expects nationwide insurance penetration growth to reflect in patient mix at all three hospitals, sustaining the trajectory from current 56.3% insurance share.
Doiwali (Thane) hospital is on track to begin operations in Q1 of next financial year (FY27) with recruitment discussions commenced.
South Pune hospital construction has commenced in Q3 FY26, marking the second greenfield project after Diwali.
Individual mature hospitals expected to achieve mid-20% EBITDA margins; new hospitals expected to be EBITDA negative in Year 1 and break-even in Year 2 (requiring ~40-45% occupancy).
Break-even typically occurs at 40-45% occupancy for new hospitals based on company's experience; expansion phases triggered once existing phase reaches 60% occupancy.
The new Dombivli hospital is expected to break even by end of year two from opening, with typical ramp-up following the company's established 2-3 year stabilization period for new facilities.
Beginning next quarter, consolidated depreciation will be significantly higher due to Dombivli capitalization, with EBITDA drag expected for approximately 2 years before the new hospital starts contributing.
Management explicitly stated they do not track ARPOB internally and have no targets. Mature hospitals are expected to grow ARPOB in line with inflation, while newer hospitals will see faster growth until maturity.
Pune South project is in early construction stage (excavation complete, basement work underway) with target launch in calendar year 2028.
Two years from February 2026 commissioning, the Dombivli hospital should achieve EBITDA breakeven, with insurance empanelment expected in 6-12 months post-accredititation.
At current capacity, Thane should grow at inflation-linked rates while Pune will benefit from occupancy expansion and case mix improvement. Indore has all three growth levers active.
Pune South expansion on track for CY28 opening as committed. Mira Road has completed architectural drawings and expects excavation to begin by year-end.
Internal cash generation over next 4-5 years combined with debt up to 3x EBITDA should fund all announced projects including BKC without requiring external capital.